BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21941092)

  • 1. Enhanced immune response and protective efficacy of a Treponema pallidum Tp92 DNA vaccine vectored by chitosan nanoparticles and adjuvanted with IL-2.
    Zhao F; Wu Y; Zhang X; Yu J; Gu W; Liu S; Zeng T; Zhang Y; Wang S
    Hum Vaccin; 2011 Oct; 7(10):1083-9. PubMed ID: 21941092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the immune responses to Treponema pallidum Gpd DNA vaccine adjuvanted with IL-2 and chitosan nanoparticles before and after Treponema pallidum challenge in rabbits.
    Zhao F; Zhang X; Liu S; Zeng T; Yu J; Gu W; Zhang Y; Chen X; Wu Y
    Sci China Life Sci; 2013 Feb; 56(2):174-80. PubMed ID: 23334700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective efficacy of a Treponema pallidum Gpd DNA vaccine vectored by chitosan nanoparticles and fused with interleukin-2.
    Zhao F; Wang S; Zhang X; Gu W; Yu J; Liu S; Zeng T; Zhang Y; Wu Y
    Can J Microbiol; 2012 Feb; 58(2):117-23. PubMed ID: 22260167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG adjuvant enhances the mucosal immunogenicity and efficacy of a Treponema pallidum DNA vaccine in rabbits.
    Zhao F; Liu S; Zhang X; Yu J; Zeng T; Gu W; Cao X; Chen X; Wu Y
    Hum Vaccin Immunother; 2013 Apr; 9(4):753-60. PubMed ID: 23563515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opsonic potential, protective capacity, and sequence conservation of the Treponema pallidum subspecies pallidum Tp92.
    Cameron CE; Lukehart SA; Castro C; Molini B; Godornes C; Van Voorhis WC
    J Infect Dis; 2000 Apr; 181(4):1401-13. PubMed ID: 10762571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cellular immunity induced by H.pylori vaccine with chitosan as adjuvant].
    Gong YF; Xie Y; Zhou NJ; Chen J; Zhou XJ; Lu NH; Wang CW
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):595-9. PubMed ID: 17618575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cloning and expression of outer membrane protein gene Gpd from Treponema pallidum and preliminary studies on its immunogenicity in rabbits].
    Zhao FJ; Wu YM; Zhang XH; Liu SQ; Yu MJ
    Wei Sheng Wu Xue Bao; 2005 Oct; 45(5):767-71. PubMed ID: 16342773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promotion of immunity of mice to Pasteurella multocida and hog cholera vaccine by pig interleukin-6 gene and CpG motifs.
    Zhao ZZ; Zhang HB; Chen Q; Su D; Xie Z; Wang YY; Yang Y; Wang ZZ; Li JL; Wu KY; Wang HN; Meng MJ; Gao R
    Comp Immunol Microbiol Infect Dis; 2009 May; 32(3):191-205. PubMed ID: 18279956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.
    Rollman E; Mathy N; Bråve A; Boberg A; Kjerrström A; van Wely C; Engström G; Johansson S; Aperia K; Eriksson LE; Benthin R; Ertl P; Heeney J; Hinkula J; Voss G; Wahren B
    Vaccine; 2007 Mar; 25(11):2145-54. PubMed ID: 17254672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal immunization with chitosan/pCETP nanoparticles inhibits atherosclerosis in a rabbit model of atherosclerosis.
    Yuan X; Yang X; Cai D; Mao D; Wu J; Zong L; Liu J
    Vaccine; 2008 Jul; 26(29-30):3727-34. PubMed ID: 18524427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
    J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of immune response in sheep immunized with DNA vaccine encoding Toxoplasma gondii GRA7 antigen in different adjuvant formulations.
    Hiszczyńska-Sawicka E; Li H; Xu JB; Oledzka G; Kur J; Bickerstaffe R; Stankiewicz M
    Exp Parasitol; 2010 Apr; 124(4):365-72. PubMed ID: 19962376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of rabbits with recombinant Treponema pallidum surface antigen 4D alters the course of experimental syphilis.
    Borenstein LA; Radolf JD; Fehniger TE; Blanco DR; Miller JN; Lovett MA
    J Immunol; 1988 Apr; 140(7):2415-21. PubMed ID: 2450921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the immunogenicity of an alphavirus replicon-based DNA vaccine against classical swine fever by electroporation and coinjection with a plasmid expressing porcine interleukin 2.
    Tian DY; Sun Y; Wai SF; Lee FK; Meng QL; Suen KM; Wang N; Han W; Li S; Li YF; Li D; Ling LJ; Liao YJ; Qiu HJ
    Vaccine; 2012 May; 30(24):3587-94. PubMed ID: 22469861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection.
    Brown TH; David J; Acosta-Ramirez E; Moore JM; Lee S; Zhong G; Hancock RE; Xing Z; Halperin SA; Wang J
    Vaccine; 2012 Jan; 30(2):350-60. PubMed ID: 22075089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
    Wozniak TM; Ryan AA; Triccas JA; Britton WJ
    Infect Immun; 2006 Jan; 74(1):557-65. PubMed ID: 16369012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porcine interleukin-2 gene encapsulated in chitosan nanoparticles enhances immune response of mice to piglet paratyphoid vaccine.
    Yang Y; Chen J; Li H; Wang Y; Xie Z; Wu M; Zhang H; Zhao Z; Chen Q; Fu M; Wu K; Chi C; Wang H; Gao R
    Comp Immunol Microbiol Infect Dis; 2007 Jan; 30(1):19-32. PubMed ID: 17034859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and immunological effectiveness of a swine influenza DNA vaccine encapsulated in chitosan nanoparticles.
    Zhao K; Shi X; Zhao Y; Wei H; Sun Q; Huang T; Zhang X; Wang Y
    Vaccine; 2011 Nov; 29(47):8549-56. PubMed ID: 21945253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
    Khatri K; Goyal AK; Gupta PN; Mishra N; Vyas SP
    Int J Pharm; 2008 Apr; 354(1-2):235-41. PubMed ID: 18182259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.